Harm Reduction Group AB
NOHARM | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0006261038
- LEI:
- 549300V671YSRBLSPR40
- Country:
- Sweden
- Address:
- C/O Moodeko Consulting AB, Att. Tina Hjemli, 784 33 Borlänge
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Norse Impact is a group active in the «non-smoking segment». The Group is governed by a number of subsidiaries, such as Norse Vape AS, Norse Snus AS, and Eurobrands distribution AB. The product range includes, for example, e-cigarettes and snus. Norse Impact sells its products via several physical stores, online stores, and wholesale departments around the Nordic region. The company is headquartered in Gothenburg
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Dermapharm Holding SE | Germany | DMP | |
|
Dicot Pharma AB | Sweden | DICOTBT | |
|
EARNZ PLC | United Kingdom | EARN | |
|
Eevia Health Plc | Finland | EEVIA | |
|
Egetis Therapeutics | Sweden | EGTX | |
|
ELARIS AG | Germany | ELS | |
|
Enervit | Italy | ENV | |
|
Enorama Pharma AB | Sweden | ERMA | |
|
Enzymatica AB | Sweden | ENZY | |
|
EQL Pharma AB | Sweden | EQL |